Second signals for cancer immunotherapy.
Saved in:
| Title: | Second signals for cancer immunotherapy. |
|---|---|
| Authors: | Olejniczak SH; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com., Lotze MT; Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com., Skokos D; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Sep 23; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2051-1426 |
|---|---|
| DOI: | 10.1136/jitc-2024-010530 |
